Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00721188 · ClinicalTrials.gov registry record · Phase 2

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

A Phase 2 study of Anemia, sponsored by American Regent.

Completed
Registry status
Phase 2
Development phase
11
Enrollment target
1
Study location

NCT00721188 is a Phase 2 study of Anemia that has completed, run by American Regent. The registered enrollment target is 11 participants, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00721188, a Phase 2 study of Anemia, has completed, sponsored by American Regent.

COMPLETED
Registry status
Phase 2
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.

Conditions Studied

Anemia

Interventions

  • DRUG Venofer

Study Locations (1)

Pennsylvania

  • Luitpold Pharmaceuticals - Norristown

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2006-01
Est. Completion 2010-01
Phase Phase 2

Sponsor

American Regent

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00721188

The ClinicalTrials.gov registry entry for NCT00721188 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 427-participant average among 72 other Anemia trials with a reported enrollment target (97% lower). The listed sponsor is American Regent, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which Venofer is the first listed.

NCT00721188 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00721188 about?

NCT00721188 is a clinical study titled "Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients". The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.

What is the current status of trial NCT00721188?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2006-01. Estimated completion is 2010-01.

What conditions does trial NCT00721188 study?

This clinical trial studies the following conditions: Anemia.

What interventions are being tested in trial NCT00721188?

The interventions under investigation include: Venofer (DRUG).

Who is sponsoring clinical trial NCT00721188?

This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00721188 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anemia

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.